These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7887242

  • 1. Lessons from preclinical and clinical studies with 1,2-diethyl-3-hydroxypyridin-4-one, CP94 and related compounds.
    Porter JB, Singh S, Hoyes KP, Epemolu O, Abeysinghe RD, Hider RC.
    Adv Exp Med Biol; 1994; 356():361-70. PubMed ID: 7887242
    [No Abstract] [Full Text] [Related]

  • 2. Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
    Kontoghiorghes GJ, Kolnagou A.
    Lancet; 2003 Jan 11; 361(9352):184. PubMed ID: 12531621
    [No Abstract] [Full Text] [Related]

  • 3. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site.
    Porter JB, Abeysinghe RD, Hoyes KP, Barra C, Huehns ER, Brooks PN, Blackwell MP, Araneta M, Brittenham G, Singh S.
    Br J Haematol; 1993 Sep 11; 85(1):159-68. PubMed ID: 8251385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy.
    Kolnagou A, Kleanthous M, Kontoghiorghes GJ.
    Hemoglobin; 2011 Sep 11; 35(3):186-98. PubMed ID: 21599431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
    Brittenham GM, Nathan DG, Olivieri NF, Pippard MJ, Weatherall DJ.
    Lancet; 2003 Jan 11; 361(9352):183; author reply 183-4. PubMed ID: 12531619
    [No Abstract] [Full Text] [Related]

  • 10. An orally active iron chelator.
    Nathan DG.
    N Engl J Med; 1995 Apr 06; 332(14):953-4. PubMed ID: 7877655
    [No Abstract] [Full Text] [Related]

  • 11. Do we need more iron-chelating drugs?
    Kontoghiorghes GJ.
    Lancet; 2003 Aug 09; 362(9382):495-6. PubMed ID: 12927446
    [No Abstract] [Full Text] [Related]

  • 12. Long term deferiprone chelation therapy.
    Hoffbrand VA, Wonke B.
    Adv Exp Med Biol; 2002 Aug 09; 509():127-39. PubMed ID: 12572992
    [No Abstract] [Full Text] [Related]

  • 13. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP, Porter JB.
    Br J Haematol; 1993 Oct 09; 85(2):393-400. PubMed ID: 8280612
    [Abstract] [Full Text] [Related]

  • 14. The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.
    Epemolu OR, Singh S, Hider RC, Damani LA.
    Drug Metab Dispos; 1992 Oct 09; 20(5):736-41. PubMed ID: 1358580
    [Abstract] [Full Text] [Related]

  • 15. New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores.
    Kolnagou A, Kontoghiorghes GJ.
    Br J Haematol; 2010 Aug 09; 150(4):489-90; author reply 491. PubMed ID: 20507309
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adherence to desferrioxamine and deferiprone and the impact of deferiprone co-prescription in thalassaemia major patients. Does the addition of deferiprone improve adherence?
    Kidson-Gerber G, Lindeman R.
    Br J Haematol; 2008 Aug 09; 142(4):679-80. PubMed ID: 18537970
    [No Abstract] [Full Text] [Related]

  • 18. Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice.
    Smith AG, Clothier B, Francis JE, Gibbs AH, De Matteis F, Hider RC.
    Blood; 1997 Feb 01; 89(3):1045-51. PubMed ID: 9028337
    [Abstract] [Full Text] [Related]

  • 19. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates.
    Liu DY, Liu ZD, Piyamongkol S, Lu SL, Hider RC.
    J Pharm Pharmacol; 2002 Jul 01; 54(7):951-7. PubMed ID: 12162714
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.